Association of Respiratory Syncytial Virus Toll-Like Receptor 3-Mediated Immune Response with COPD Exacerbation Frequency

Inflammation

Volumn 41, Issue 2, 2018, Pages 654-666

  Liu, Daishun ^a   Chen, Qian ^a   Zhu, Honglan ^a   Gong, Ling ^a   Huang, Yi ^a   Li, Shiguang ^a   Yue, Changwu ^a   Wu, Kaifeng ^a   Wu, Yang ^a   Zhang, Wei ^a   Huang, Guichuan ^a   Zhang, Ling ^a   Pu, Shenglan ^b   Wang, Daoxin ^b  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

AECOPD; immune response; RSV; TLR3

Indexed keywords

BETA ACTIN; BETA INTERFERON; COMPLEMENTARY DNA; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 6; MESSENGER RNA; PROCALCITONIN; TOLL LIKE RECEPTOR 3; IRF3 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN;

A-549 CELL LINE; ADULT; AGED; ANTIBODY TITER; ARTICLE; CELL NUCLEUS TRANSPLANTATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; LUNG EPITHELIUM; LUNG FUNCTION; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME TO TREATMENT; WESTERN BLOTTING; CASE CONTROL STUDY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PNEUMOVIRUS; VIROLOGY;

A549 CELLS; CASE-CONTROL STUDIES; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; INTERLEUKIN-6; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER; TOLL-LIKE RECEPTOR 3;

EID: 85038619898     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-017-0720-4     Document Type: Article

References (45)

1. Bozinovski, S., A. Hutchinson, M. Thompson, et al. 2008. Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 177 (3): 269–278.
2. Sapey, E., and R.A. Stockley. 2006. COPD exacerbations: 2. Aetiology. Thorax 61 (3): 250–258.
3. Rohde, G., A. Wiethege, I. Borg, et al. 2003. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58 (1): 37–42.
4. Beckham, J.D., A. Cadena, J. Lin, et al. 2005. Respiratory viral infections in patients with chronic obstructive pulmonary disease. The Journal of Infection 50 (4): 322–330.
5. Falsey, A.R., M.C. Criddle, and E.E. Walsh. 2006. Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness. Journal of Clinical Virology 35 (1): 46–50.
6. Falsey, A.R., M.A. Formica, P.A. Hennessey, M.M. Criddle, W.M. Sullender, and E.E. Walsh. 2006. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 173 (6): 639–643.
7. Walsh, E.E., D.R. Peterson, and A.R. Falsey. 2004. Risk factors for severe respiratory syncytial virus infection in elderly persons. The Journal of Infectious Diseases 189 (2): 233–238.
8. Zhang, S.Y., M. Herman, M.J. Ciancanelli, et al. 2013. TLR3 immunity to infection in mice and humans. Current Opinion in Immunology 25 (1): 19–33.
9. Jin, Y.H., T. Kaneyama, M.H. Kang, H.S. Kang, C.S. Koh, and B.S. Kim. 2011. TLR3 signaling is either protective or pathogenic for the development of Theiler’s virus-induced demyelinating disease depending on the time of viral infection. Journal of Neuroinflammation 8: 178.
10. Le Goffic, R., V. Balloy, M. Lagranderie, et al. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathogens 2: e53.
11. Gowen, B.B., J.D. Hoopes, M.H. Wong, et al. 2006. TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. Journal of Immunology 177 (9): 6301–6307.
12. Hutchens, M., K.E. Luker, P. Sottile, et al. 2008. TLR3 increases disease morbidity and mortality from vaccinia infection. Journal of Immunology 180 (1): 483–491.
13. Wang, T., T. Town, L. Alexopoulou, J.F. Anderson, E. Fikrig, and R.A. Flavell. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nature Medicine 10 (12): 1366–1373.
14. Perez de Diego, R., V. Sancho-Shimizu, L. Lorenzo, et al. 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33 (3): 400–411.
15. Dupuis, S., E. Jouanguy, S. Al-Hajjar, et al. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nature Genetics 33 (3): 388–391.
16. Niehues, T., J. Reichenbach, J. Neubert, et al. 2004. ANEMO-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. The Journal of Allergy and Clinical Immunology 114 (6): 1456–1462.
17. Kindberg, Elin, Sirkka Vene, Aukse Mickiene, Ake Lundkvist, Lars Lindquist, and Lennart Svensson. 2011. A functional toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection. The Journal of Infectious Diseases 203 (4): 523–528.
18. Barkhash, A.V., M.I. Voevoda, and A.G. Romaschenko. 2013. Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population. Antiviral Research 99 (2): 136–138.
19. Kinose, D., et al. 2016. Association of COPD exacerbation frequency with gene expression of pattern recognition receptors in inflammatory cells in induced sputum. The Clinical Respiratory Journal 10 (1): 11–21.
20. Pauwels, R.A., A.S. Buist, P.M. Calverley, C.R. Jenkins, and S.S. Hurd. 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. American Journal of Respiratory and Critical Care Medicine 163 (5): 1256–1276.
21. Sachs, L.A., D. Schnurr, S. Yagi, M.E. Lachowicz-Scroggins, and J.H. Widdicombe. 2011. Quantitative real-time PCR for rhinovirus, and its use in determining the relationship between TCID50 and the number of viral particles. Journal of Virological Methods 171 (1): 212–218.
22. Kadowaki, N., S. Ho, S. Antonenko, et al. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. The Journal of Experimental Medicine 194 (6): 863–869.
23. Tabiasco, J., E. Devevre, N. Rufer, et al. 2006. Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. Journal of Immunology 177 (12): 8708–8713.
24. Schmidt, K.N., B. Leung, M. Kwong, et al. 2004. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. Journal of Immunology 172 (1): 138–143.
25. Kumar, M.V., C.N. Nagineni, M.S. Chin, J.J. Hooks, and B. Detrick. 2004. Innate immunity in the retina. Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. Journal of Neuroimmunology 153 (1–2): 7–15.
26. Sun, J., K.E. Duffy, C.T. Ranjith-Kumar, et al. 2006. Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J Biol Chem 281 (16): 11144–11151.
27. Nakamura, M., K. Funami, A. Komori, et al. 2008. Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers. Hepatology International 2 (2): 222–230.
28. Cario, E., and D.K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infection and Immunity 68 (12): 7010–7017.
29. Lebre, M.C., A.M. van der Aar, L. van Baarsen, et al. 2007. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. The Journal of Investigative Dermatology 127 (2): 331–341.
30. Zhang, S.Y., E. Jouanguy, S. Ugolini, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317 (5844): 1522–1527.
31. Casrouge, A., S.Y. Zhang, C. Eidenschenk, et al. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314 (5797): 308–312.
32. Zimmer, S., M. Steinmetz, T. Asdonk, et al. 2011. Activation of endothelial toll-like receptor 3 impairs endothelial function. Circulation Research 108 (11): 1358–1366.
33. Wang, N., Y. Liang, S. Devaraj, J. Wang, S.M. Lemon, and K. Li. 2009. Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. Journal of Virology 83 (19): 9824–9834.
34. Jackson, A.C., J.P. Rossiter, and M. Lafon. 2006. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. Journal of Neurovirology 12 (3): 229–234.
35. Prehaud, C., F. Megret, M. Lafage, and M. Lafon. 2005. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. Journal of Virology 79 (20): 12893–12904.
36. Wilkinson, Tom M.A., Gavin C. Donaldson, et al. 2006. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med Vol 173 (8): 871–876.
37. Borg, I., G. Rohde, S. Loseke, et al. 2003. Evaluation of quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. The European Respiratory Journal 21 (6): 944–951.
38. Stein, R.T., D. Sherrill, W.J. Morgan, et al. 1999. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 (9178): 541–545.
39. Monick, M.M., T.O. Yarovinsky, L.S. Powers, et al. 2003. Respiratory syncytial virus upregulates TLR4 and sensitizes airway epithelial cells to endotoxin. The Journal of Biological Chemistry 278 (52): 55035–55044.
40. Wang, S.Z., H. Xu, A. Wraith, J.J. Bowden, J.H. Alpers, and K.D. Forsyth. 1998. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. The European Respiratory Journal 12 (3): 612–618.
41. Botos, I., D.M. Segal, and D.R. Davies. 2011. The structural biology of Toll-like receptors. Structure 19 (4): 447–459.
42. Yamamoto, M., S. Sato, H. Hemmi, et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (5633): 640–643.
43. O’Neill, L.A., and A.G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews. Immunology 7 (5): 353–364.
44. Doyle, S., S. Vaidya, R. O’Connell, et al. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17 (3): 251–263.
45. Groskreutz, D.J., M.M. Monick, L.S. Powers, T.O. Yarovinsky, D.C. Look, and G.W. Hunninghake. 2006. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. Journal of Immunology 176 (3): 1733–1740.